German biotech CureVac, which is developing a coronavirus vaccine, has filed for a U.S. IPO, reported Reuters. CureVac’s backers include Qatar Investment Authority and GlaxoSmithKline Plc.
Source: Reuters
CureVac files for U.S. IPO: Reuters
German biotech CureVac, which is developing a coronavirus vaccine, has filed for a U.S. IPO, reported Reuters.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.